XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Employee Benefit Plans (Tables)
 12 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Summary of activity with respect to stock options
A summary of activity in the Omnibus Incentive Plans with respect to our stock options for Fiscal 2022 is as follows:
OptionsWeighted
Average
Exercise
Price Per
Share		Weighted
Average
Remaining
Contractual
Life		Aggregate
Intrinsic
Value
(In thousands)(Years)(In thousands)
Options outstanding at March 31, 20215,623 $4.10 6.811,659 
Granted932 4.95 
Exercised(489)2.89 
Forfeited(123)4.88 
Expired— — 
Options outstanding at March 31, 20225,943 4.32 6.5974 
Summary of activity with respect to RSUs
A summary of activity with respect to our RSUs for Fiscal 2022 is as follows:
# of SharesWeighted
Average
Price Per
Share		Weighted
Average
Remaining
Life		Aggregate
Intrinsic
Value
(In thousands)(Years)(In thousands)
RSUs outstanding at March 31, 2021448 $4.08 7.82,764 
Granted191 5.00 
Vested(184)4.92 
Forfeited(4)4.80 
RSUs outstanding at March 31, 2022451 4.12 7.51,271 
Summary of the details of performance stock units The following table summarizes the details of the performance stock units:
# of SharesWeighted Average Price Per Share
(In thousands)
PSUs outstanding at March 31, 202168 $5.47 
Granted64 7.26 
Forfeited(17)6.37 
PSUs outstanding at March 31, 20221156.33 
Schedule of stock-based compensation expense
The following table presents stock-based compensation expense that is included in each functional line item in our consolidated statements of operations:
Year Ended March 31,
202220212020
(In thousands)
Cost of revenues$242 $209 $143 
General and Administrative2,574 2,359 2,116 
Sales and marketing340 158 156 
Research and development expense245 134 81 
Restructuring activities— 42 — 
Loss from discontinued operations— (57)290 
Total stock-based compensation$3,401 $2,845 $2,785 
Schedule of weighted-average assumptions used in estimating the grant date fair value of stock options granted
The grant date fair value of stock options granted was estimated using the following weighted-average assumptions:
Year Ended March 31,
202220212020
Expected life—years7.26.76.8
Risk-free interest rate1.5 %1.0 %2.2 %
Expected volatility of common stock49 %47 %47 %
Dividend yield0 %0 %0 %
Summary of certain fair value and intrinsic value information pertaining to stock options
A summary of certain fair value and intrinsic value information pertaining to our stock options is as follows:
Year Ended March 31,
202220212020
(In thousands, except
per share amounts)
Weighted average grant date fair value per share of options granted$2.58 $2.38 $2.52 
Intrinsic value of options exercised$1,966 $1,494 $378